Funding Spotlight


Revolutionizing Cryopreservation for Bioproducts
Industry: Biopreservation
Seeking: $10M Series A
Opportunity: SmartBio is developing next-generation technologies for enhanced cryopreservation of cells and tissues, addressing critical unmet needs in cell therapy, regenerative medicine, and biopharmaceuticals. Their propietary solutions-SmartThaw, RevitallCE, and ChillOut-promise improved efficacy, recovery, and scalability for biological samples.
Market Potential: The biopreservation market is projected to grow from $4.4B in 2024 to $7.1B by 2029 (CAGR 9.8%). With even 1% market penetration, SmartBio could generate revenues exceeding $400M annually.
Milestones Post-Funding:
Projected Exit: $175M - $200M M&A value within 3 years.

